Optimising HPV vaccination communication to adolescents: A discrete choice experiment

被引:19
作者
Chyderiotis, Sandra [1 ]
Sicsic, Jonathan [2 ]
Raude, Jocelyn [3 ,4 ]
Bonmarin, Isabelle [5 ]
Jeanleboeuf, Florian [6 ,7 ]
Banaszuk, Anne-Sophie Le Duc [8 ]
Gauchet, Aurelie [9 ]
Bruel, Sebastien [10 ,11 ]
Michel, Morgane [12 ,13 ,14 ]
Giraudeau, Bruno [15 ,16 ]
Thilly, Nathalie [17 ,18 ]
Mueller, Judith E. [1 ,3 ]
机构
[1] Inst Pasteur, Unite Rech & Expertise Epidemiol Malad Emergentes, 25 Rue Dr Roux, F-75724 Paris 15, France
[2] Univ Paris, LIRAES EA 4470, Paris, France
[3] Univ Sorbonne Paris Cite, EHESP Rennes, Paris, France
[4] Unite Virus Emergents UVE Aix Marseille Univ IRD, Marseille, France
[5] Sante Publ France, St Maurice, France
[6] Univ Lyon, GIMAP Grp Immunite Muqueuses & Agents Pathogenes, EA 3064, Univ Jean Monnet, St Etienne, France
[7] Univ Lyon, Chaire PREVacCI Prevent Vaccinat & Controle Infec, Inst PRESAGE, Univ Jean Monnet, St Etienne, France
[8] Ctr Reg Coordinat Depistages Canc Pays Loire, Angers, France
[9] Univ Grenoble Alpes, LIP PC2S, EA 4145, Grenoble, France
[10] St Etienne Lyon Univ, HESPER EA7425, St Etienne, France
[11] Univ Hosp St Etienne, CIC INSERM 1408, St Etienne, France
[12] Univ Paris, ECEVE, Paris, France
[13] Hop Robert Debre, Assistance Publ Hop Paris, Hotel Dieu, URC Eco Ile de France,Unite Epidemiol Clin, Paris, France
[14] ECEVE, INSERM, UMR 1123, Paris, France
[15] Univ Nantes, Univ Tours, INSERM, SPHERE U1246, Tours, France
[16] CHRU Tours, INSERM CIC 1415, Tours, France
[17] Univ Lorraine, APEMAC, Nancy, France
[18] Univ Lorraine, CHRU Nancy, Dept Methodol, Promot,Invest, Nancy, France
关键词
HPV; Vaccine acceptance; Discrete choice experiment; France; Adolescents; Communication; HUMAN-PAPILLOMAVIRUS VACCINATION; CONJOINT-ANALYSIS; PREFERENCES; BENEFITS; COVERAGE; DISEASES; PARENT; GIRLS;
D O I
10.1016/j.vaccine.2021.05.061
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Human Papillomavirus (HPV) vaccine coverage in France is below 30%, despite proven effectiveness against HPV infections and (pre-)cancerous cervical lesions. To optimise vaccine promotion among adolescents, we used a discrete choice experiment (DCE) to identify optimal statements regarding a vaccination programme, including vaccine characteristics. Methods: Girls and boys enrolled in the last two years of five middle schools in three French regions (aged 13-15 years) participated in an in-class cross-sectional self-administered internet-based study. In ten hypothetical scenarios, participants decided for or against signing up for a school-based vaccination campaign against an unnamed disease. Scenarios included different levels of four attributes: the type of vaccine-preventable disease, communication on vaccine safety, potential for indirect protection, and information on vaccine uptake among peers. One scenario was repeated with an added mention of sexual transmission. Results: The 1,458 participating adolescents (estimated response rate: 89.4%) theoretically accepted vaccination in 80.1% of scenarios. All attributes significantly impacted theoretical vaccine acceptance. Compared to a febrile respiratory disease, protection against cancer was motivating (odds ratio (OR) 1.29 [95%-CI 1.09-1.52]), but not against genital warts (OR 0.91 [0.78-1.06]). Compared to risk negation ("vaccine does not provoke serious side effects"), a reference to a positive benefit-risk balance despite a confirmed side effect was strongly dissuasive (OR 0.30 [0.24-0.36]), while reference to ongoing international pharmacovigilance without any scientifically confirmed effect was not significantly dissuasive (OR 0.86 [0.71-1.04]). The potential for indirect protection motivated acceptance among girls but not boys (potential for eliminating the disease compared to no indirect protection, OR 1.57 [1.25-1.96]). Compared to mentioning "insufficient coverage", reporting that ">80% of young people in other countries got vaccinated" motivated vaccine acceptance (OR 1.94 [1.61-2.35]). The notion of sexual transmission did not influence acceptance. Conclusion: HPV vaccine communication to adolescents can be tailored to optimise the impact of promotion efforts. (c) 2021 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3916 / 3925
页数:10
相关论文
共 47 条
[1]  
Amessi L, 2016, CONNAISSANCES INFECT
[2]  
Bansal Anshuma, 2016, Int J Appl Basic Med Res, V6, P84, DOI 10.4103/2229-516X.179027
[3]   Effect of the decision-making process in the family on HPV vaccination rates among adolescents 9-17 years of age [J].
Berenson, Abbey B. ;
Laz, Tabassum H. ;
Hirth, Jacqueline M. ;
McGrath, Christine J. ;
Rahman, Mahbubur .
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (07) :1807-1811
[4]   Debunking Vaccination Myths: Strong Risk Negations Can Increase Perceived Vaccination Risks [J].
Betsch, Cornelia ;
Sachse, Katharina .
HEALTH PSYCHOLOGY, 2013, 32 (02) :146-155
[5]   Male Human Papillomavirus Vaccine Acceptance Is Enhanced by a Brief Intervention that Emphasizes Both Male-Specific Vaccine Benefits and Altruistic Motives [J].
Bonafide, Katherine E. ;
Vanable, Peter A. .
SEXUALLY TRANSMITTED DISEASES, 2015, 42 (02) :76-80
[6]   Conjoint Analysis Applications in Health-a Checklist: A Report of the ISPOR Good Research Practices for Conjoint Analysis Task Force [J].
Bridges, John F. P. ;
Hauber, A. Brett ;
Marshall, Deborah ;
Lloyd, Andrew ;
Prosser, Lisa A. ;
Regier, Dean A. ;
Johnson, F. Reed ;
Mauskopf, Josephine .
VALUE IN HEALTH, 2011, 14 (04) :403-413
[7]   Adolescent-Parent Dyad Descriptions of the Decision to Start the HPV Vaccine Series [J].
Chang, Jane ;
Ipp, Lisa S. ;
de Roche, Ariel M. ;
Catallozzi, Marina ;
Breitkopf, Carmen Radecki ;
Rosenthal, Susan L. .
JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY, 2018, 31 (01) :28-32
[8]  
Dayan J, 2011, ADOLESCENCE, V3, P479, DOI DOI 10.3917/AD0.077.0479
[9]   Discrete choice experiments in health economics: a review of the literature [J].
de Bekker-Grob, Esther W. ;
Ryan, Mandy ;
Gerard, Karen .
HEALTH ECONOMICS, 2012, 21 (02) :145-172
[10]   Girls' preferences for HPV vaccination: A discrete choice experiment [J].
de Bekker-Grob, Esther W. ;
Hofman, Robine ;
Donkers, Bas ;
van Ballegooijen, Marjolein ;
Helmerhorst, Theo J. M. ;
Raat, Hein ;
Korfage, Ida J. .
VACCINE, 2010, 28 (41) :6692-6697